SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,826 | -47.8% | 15,053 | +24.4% | 0.00% | – |
| Q1 2023 | $68,596 | -62.5% | 12,098 | -63.0% | 0.00% | – |
| Q4 2022 | $182,879 | -37.4% | 32,657 | -21.9% | 0.00% | -100.0% |
| Q3 2021 | $292,000 | -75.8% | 41,791 | -17.4% | 0.00% | -80.0% |
| Q2 2021 | $1,207,000 | -9.7% | 50,605 | +7.2% | 0.01% | -28.6% |
| Q3 2020 | $1,336,000 | +1435.6% | 47,187 | +75.5% | 0.01% | +600.0% |
| Q2 2019 | $87,000 | +8600.0% | 26,886 | +26786.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |